InVivoSIM anti-human IL-17A (Secukinumab Biosimilar)
SIM0013
ApplicationsFunctional Assay, Flow Cytometry, ImmunoFluorescence, ELISA, ImmunoHistoChemistry, Neutralisation/Blocking
Product group Antibodies
Overview
- SupplierBio X Cell
- Product NameInVivoSIM anti-human IL-17A (Secukinumab Biosimilar)
- Delivery Days Customer7
- ApplicationsFunctional Assay, Flow Cytometry, ImmunoFluorescence, ELISA, ImmunoHistoChemistry, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDSecukinumab
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostHuman
- IsotypeIgG1
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Wang F, Li Y, Yang Z, et al. Targeting IL-17A enhances imatinib efficacy in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia. Nat Commun. 2024,15(1):203. doi: 10.1038/s41467-023-44270-3Read this paper
